Clinical Trial Update: Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study [Phase 4]

View source ↗

Summary

Phase 4 multicenter randomized trial evaluating a fixed-dose combination of henagliflozin proline with metformin extended-release versus metformin alone in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozin Proline (henagliflozin proline)
• Metformin Hydrochloride Extended-release Tablets (metformin hydrochloride extended-release)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: New-onset Type 2 Diabetes | Phase 4 | Status: RECRUITING